Phase 2 HR-positive,HER2-negative Breast Cancer Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Neoadjuvant QL1706 in Patients With Hormone Receptor Positive, HER2-negative Breast Cancer
HR-positive,HER2-negative Breast Cancer
RenJi Hospital55 enrolled1 locationNCT07396324
Recruiting
Phase 2
Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.
HR-positive,HER2-negative Breast Cancer
First Affiliated Hospital of Zhejiang University30 enrolled1 locationNCT06705127